News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Results from Event-free survival (EFS) in Matterhorn – Memorial Sloan Kettering Cancer Center
Yelena Janjigian/LinkedIn
Jun 1, 2025, 04:49

Results from Event-free survival (EFS) in Matterhorn – Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:

“Plenary session alert: MSK gastrointestinal oncologist Dr. Yelena Janjigian.
Will share results from “Event-free survival (EFS) in MATTERHORN: A randomized, phase 3 study of durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel chemotherapy (FLOT) in resectable gastric/gastroesophageal junction cancer (GC/GEJC)” TODAY at the American Society of Clinical Oncology (ASCO) Annual Meeting.
Date: 6/1 at 3:13pm CT.”

Memorial Sloan Kettering announced that Dr. Yelena Janjigian will present results from the MATTERHORN phase 3 trial during a plenary session at ASCO. The study evaluates event-free survival for durvalumab in combination with FLOT chemotherapy in patients with resectable gastric or gastroesophageal junction cancer.

More posts featuring Memorial Sloan Kettering Cancer Center.

American Society of Clinical Oncology ASCO cancer Durvalumab fight against cancer fluorouracil gastroesophageal junction cancer Global fight against cancer leucovorin MATTERHORN Memorial Sloan Kettering Cancer Center MSKCC OncoDaily Oncology oxaliplatin oxaliplatin and docetaxel chemotherapy Yelena Janjigian
Special Coverage
Career
Jun 4, 2025, 17:30
Fellowship and Short-Term Training Opportunities Now Open at POEM Training Centers - POEM Group
Celebrities
Jun 4, 2025, 17:16
Jessie J Diagnosed with Early-Stage Breast Cancer: What Is the Prognosis?
Blog
Jun 4, 2025, 17:13
Katy Rezvani Has Been Appointed as AACR 2026 Program Committee Co-Chair and Elected to the Association of American Physicians
Blog
Jun 4, 2025, 17:07
Teresa Amaral: The Fantastic Faculty of The ASCO and ESMO Session at ASCO25 Congress
Blog
Jun 4, 2025, 17:02
Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Blog
Jun 4, 2025, 16:52
Olubukola Ayodele: I Leave ASCO25 Feeling Recharged Not Just By Data But By Direction
Insight
Jun 4, 2025, 16:33
Paolo Tarantino on Sara Tolaney’s Leadership and Mentorship at ASCO 2025
Blog
Jun 4, 2025, 16:33
Maryam Lustberg: Grateful For My MASCC Family
Insight
Jun 4, 2025, 16:30
Jasmine Kamboj Celebrated ASCO Advocacy Award with Team Minnesota at ASCO 2025
Blog
Jun 4, 2025, 16:27
Hadieh Eslampanah: Happy International Cancer Survivors Day 2025 - New Life and New Beginning
Oncolibrary
Jun 4, 2025, 16:20
IMMUNOSARC II Study Results: Sunitinib Plus Nivolumab Shows Promising Activity in Advanced Extraskeletal Myxoid Chondrosarcoma (EMC)
Blog
Jun 4, 2025, 15:56
SIOG Announces Interactive Geriatric Assessment Workshop for SIOG 2025